E. Pyott David - 23 Feb 2023 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Andrew Mayer, Attorney-in-Fact For: David E.I. Pyott
Issuer symbol
ALNY
Transactions as of
23 Feb 2023
Transactions value $
$0
Form type
4
Date filed
27 Feb 2023, 15:13
Previous filing
21 Jun 2022
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $0 +136 $0.00 136 23 Feb 2023 Direct
holding ALNY Common Stock 27.9K 23 Feb 2023 by Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Restricted Stock Units Options Exercise $0 -136 -100% $0.00* 0 23 Feb 2023 Common Stock 136 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee.
F2 Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.
F3 This award vested on February 23, 2023, the first anniversary of the grant date.